Human Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide

• Catalog number
  LEAP22-P
• Price
  Please ask
• Size
  100 ug

• Stock availability
  Available
• Category
  Antibody Blocking Peptide
• Antibody type
  N/A
• Antibody host
  N/A
• Antibody conjugate
  N/A
• Technical datasheet
  Contact Gentaur to request the datasheet or ask our specialists for more information.
• Notes
  The Human Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide is manufactured for Research Use Only or for diagnostics purposes.
• Other related products
• Test
  You can block the antibody by the specific target amino acid sequence of peptide.
• Properties
  blocking peptide, Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
• Description
  Isotype or positive controls by peptides, antibodies and deactivated samples. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

• Gene target
  Liver-expressed   antimicrobial   peptide   LEAP2  
• Gene symbol
  LEAP2
• Short name
  Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide
• Technique
  blocking peptide, Blocking, Control, peptide, blocking peptides, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. controls, peptides
• Species
  Human, Humans
• Alternative name
  H. sapiens Liver-expressed antimicrobial short protein sequence 2 (liver expressed antimicrobial peptide 2) reference/inhibiting short protein sequence
• Alternative technique
  control, peptides, controls
• Alternative to gene target
  liver expressed antimicrobial peptide 2, LEAP2 and IDBG-43708 and ENSG00000164406 and 116842, Extracellular, Leap2 and IDBG-171608 and ENSMUSG00000036216 and 259301, LEAP2 and IDBG-645718 and ENSBTAG00000018926 and 282270
• Tissue
  control, liver

Gene info

• Identity
  HGNC:29571
• Gene
  LEAP2
• Long gene name
  liver enriched antimicrobial peptide 2
• Synonyms gene name
  • liver expressed antimicrobial peptide 2
• Synonyms
  • LEAP-2
• GenBank acession
  • AJ409065
  • BX443829
• Locus
  5q31.1
• Discovery year
  2006-08-22
• Entrez gene record
  116842
• Pubmed identfication
  • 12493837
• RefSeq identity
  • NM_052971
• VEGA ID
  OTTHUMG00000059837

MeSH Data

• Name
  Blotting, Western
• Concept
  Scope note: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
• Tree numbers
  • E05.196.401.143
  • E05.301.300.096
  • E05.478.566.320.200
  • E05.601.262
  • E05.601.470.320.200
• Qualifiers
  ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data

Product images

Similar products